Author:
Boender T. Sonia,Hamers Raph L.,Ondoa Pascale,Wellington Maureen,Chimbetete Cleophas,Siwale Margaret,Labib Maksimos Eman E. F.,Balinda Sheila N.,Kityo Cissy M.,Adeyemo Titilope A.,Akanmu Alani Sulaimon,Mandaliya Kishor,Botes Mariette E.,Stevens Wendy,Rinke de Wit Tobias F.,Sigaloff Kim C. E.
Funder
Ministry of Foreign Affairs of the Netherlands
Stichting AidsFonds
the Embassy of the Kingdom of the Netherlands
Heineken Africa Foundation
Jura Foundation
Netherlands Organization for Scientific Research
NWO-WOTRO
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Immunology and Allergy
Reference45 articles.
1. Joint United Nations Programme on HIV/AIDS (UNAIDS). MDG 6: 15 years, 15 lessons of hope from the AIDS response, 2015. http://www.unaids.org/en/resources/documents/2015/MDG6_15years-15lessonsfromtheAIDSresponse. Accessed April 2015.
2. World Health Organization. Antiretroviral medicines in low- and middle-income countries: forecasts of global and regional demand for 2012–2015, 2013. http://apps.who.int/iris/bitstream/10665/83148/1/9789241505468_eng.pdf. Accessed June 2013.
3. The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study
4. Haas AD , Keiser O , Balestre E et al . Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Lancet HIV 2015; 271–8.
5. CHAI (The Clinton Health Access Initiative). ARV market report—the state of the antiretroviral drug market in low- and middle-income countries, 2013.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献